Therapeutic effect of Intravesical Bacillus Calmette-Guerin(IMMUCYST) to nonmuscle-invasive urothelial carcinoma of bladder and examination of safety

Therapeutic effect of Intravesical Bacillus Calmette-Guerin(IMMUCYST) to nonmuscle-invasive urothelial carcinoma of bladder and examination of safety - Therapeutic effect of Intravesical Bacillus Calmette-Guerin to nonmuscle-invasive urothelial carcinoma of bladder and examination of safety

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004672

Enrollment

100

Registered

2010-12-08

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

tretment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CIS or high grade T1 bladder cancer

Exclusion criteria

Exclusion criteria: allergy for BCG pregnancy tuberculosis

Design outcomes

Primary

Measure	Time frame
recurrence free survival	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026